These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety. Salim I, Al Suwaidi J, Ghadban W, Salam AM. Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103 [Abstract] [Full Text] [Related]
23. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention. Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D. Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823 [Abstract] [Full Text] [Related]
24. New oral anticoagulants in elderly patients with atrial fibrillation. Deedwania PC. Am J Med; 2013 Apr; 126(4):289-96. PubMed ID: 23369212 [Abstract] [Full Text] [Related]
25. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators. Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748 [Abstract] [Full Text] [Related]
26. How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation? Quinn GR, Singer DE, Chang Y, Go AS, Borowsky LH, Fang MC. Am J Cardiol; 2016 Sep 01; 118(5):697-9. PubMed ID: 27394408 [Abstract] [Full Text] [Related]
27. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Ruiz-Nodar JM, Marín F, Roldán V, Valencia J, Manzano-Fernández S, Caballero L, Hurtado JA, Sogorb F, Valdés M, Lip GY. Circ Cardiovasc Interv; 2012 Aug 01; 5(4):459-66. PubMed ID: 22787018 [Abstract] [Full Text] [Related]
28. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M, CCS Atrial Fibrillation Guidelines Committee. Can J Cardiol; 2011 Aug 01; 27(1):74-90. PubMed ID: 21329865 [Abstract] [Full Text] [Related]
29. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project. Banerjee A, Clementy N, Haguenoer K, Fauchier L, Lip GY. Am J Med; 2014 Oct 01; 127(10):972-8. PubMed ID: 24929021 [Abstract] [Full Text] [Related]
30. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation. Assiri A, Al-Majzoub O, Kanaan AO, Donovan JL, Silva M. Clin Ther; 2013 Jul 01; 35(7):967-984.e2. PubMed ID: 23870607 [Abstract] [Full Text] [Related]
31. Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation. Myat A, Ahmad Y, Haldar S, Tantry US, Redwood SR, Gurbel PA, Lip GY. Expert Rev Cardiovasc Ther; 2013 Aug 01; 11(8):1029-49. PubMed ID: 23984927 [Abstract] [Full Text] [Related]
32. New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs. Garcia DA, Lopes RD, Hylek EM. Thromb Haemost; 2010 Dec 01; 104(6):1099-105. PubMed ID: 20886196 [Abstract] [Full Text] [Related]
33. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H, Selçuk MT, Maden O. Anadolu Kardiyol Derg; 2007 Mar 01; 7(1):54-8. PubMed ID: 17347079 [Abstract] [Full Text] [Related]
34. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY. J Am Coll Cardiol; 2012 Aug 28; 60(9):861-7. PubMed ID: 22858389 [Abstract] [Full Text] [Related]
35. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study. Lefebvre MC, St-Onge M, Glazer-Cavanagh M, Bell L, Kha Nguyen JN, Viet-Quoc Nguyen P, Tannenbaum C. Can J Cardiol; 2016 Feb 28; 32(2):169-76. PubMed ID: 26277091 [Abstract] [Full Text] [Related]
36. [Anticoagulation in atrial fibrillation. Strategies in special situations]. Volkmann H, Walter M, Walter C, Vetter S. Clin Res Cardiol Suppl; 2011 May 28; 6():58-65. PubMed ID: 22528179 [Abstract] [Full Text] [Related]
37. Atrial fibrillation and stroke prevention: brief observations on the last decade. Lip GY. Expert Rev Cardiovasc Ther; 2014 Apr 28; 12(4):403-6. PubMed ID: 24650307 [Abstract] [Full Text] [Related]
38. Novel oral anticoagulants in secondary prevention of stroke. Diener HC, Easton JD, Hankey GJ, Hart RG. Best Pract Res Clin Haematol; 2013 Jun 28; 26(2):131-9. PubMed ID: 23953901 [Abstract] [Full Text] [Related]
39. The need for new oral anticoagulants in clinical practice. Hylek EM. J Cardiovasc Med (Hagerstown); 2009 Aug 28; 10(8):605-9. PubMed ID: 19571764 [Abstract] [Full Text] [Related]
40. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY. Circ Arrhythm Electrophysiol; 2012 Apr 28; 5(2):312-8. PubMed ID: 22319005 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]